Addressing Medication Affordability in Vulnerable Patients During COVID-19
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a...
During the recent Digital Pharma Innovation Week, I had the great opportunity to lead a roundtable discussion with a group of stakeholders from across the pharma industry...
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...
Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often...
At the recent Asembia Specialty Pharmacy Summit, I had the chance to join RxNT, a leading EHR provider, to host a small-format session on the EHR workflow. In light of recent...
Growth in healthcare technology began with the HITECH (Health Information Technology for Economic and Clinical Health) Act of 2009 and has grown significantly over the years....
Every day, patients switch to new therapies because of disease progression, side effects, affordability or other factors—potentially delaying patient recoveries, negatively...
Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this...
It’s a problem with an enormous impact on patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...
In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...
If you’re a life science marketer, chances are you’ve been hearing about the difference artificial...